How Myriad Genetics Strategized to Undermind Its New Genetic Testing Competitors

Published: Nov 29, 2016

No company has had a more profound impact on inherited breast and ovarian cancer than Myriad Genetics. Its DNA test to identify women with a sharply increased chance of developing these cancers changed millions of lives: Many women who learned they had a cancer-causing mutation had their breasts and ovaries removed in an effort to dodge the genetic bullet.

Back to news